Analysis of Concomitant Medications Prescribed with Antipsychotics to Patients with Dementia.

IF 2.2 4区 医学 Q3 CLINICAL NEUROLOGY Dementia and Geriatric Cognitive Disorders Pub Date : 2023-01-01 Epub Date: 2023-05-26 DOI:10.1159/000531240
Yoshitaka Saito, Satoru Oishi, Takeya Takizawa, Hiroyuki Muraoka, Yuki Yoshimura, Itsuki Hashimoto, Ryutaro Suzuki, Tsuyoshi Ono, Ken Inada
{"title":"Analysis of Concomitant Medications Prescribed with Antipsychotics to Patients with Dementia.","authors":"Yoshitaka Saito,&nbsp;Satoru Oishi,&nbsp;Takeya Takizawa,&nbsp;Hiroyuki Muraoka,&nbsp;Yuki Yoshimura,&nbsp;Itsuki Hashimoto,&nbsp;Ryutaro Suzuki,&nbsp;Tsuyoshi Ono,&nbsp;Ken Inada","doi":"10.1159/000531240","DOIUrl":null,"url":null,"abstract":"<p><strong>Introduction: </strong>Antipsychotics are still commonly prescribed to patients with dementia, despite the many issues that have been identified. This study aimed to quantify antipsychotic prescription in patients with dementia and the types of concomitant medications prescribed with antipsychotics.</p><p><strong>Methods: </strong>A total of 1,512 outpatients with dementia who visited our department between April 1, 2013 and March 31, 2021, were included in this study. Demographic data, dementia subtypes, and regular medication use at the time of the first outpatient visit were investigated. The association between antipsychotic prescriptions and referral sources, dementia subtypes, antidementia drug use, polypharmacy, and prescription of potentially inappropriate medications (PIMs) was evaluated.</p><p><strong>Results: </strong>The antipsychotic prescription rate for patients with dementia was 11.5%. In a comparison of dementia subtypes, the antipsychotic prescription rate was significantly higher for patients with dementia with Lewy bodies (DLB) than for those with all other dementia subtypes. In terms of concomitant medications, patients taking antidementia drugs, polypharmacy, and PIMs were more likely to receive antipsychotic prescriptions than those who were not taking these medications. Multivariate logistic regression analysis showed that referrals from psychiatric institutions, DLB, N-methyl-<sc>d</sc>-aspartate (NMDA) receptor antagonists, polypharmacy, and benzodiazepine were associated with antipsychotic prescriptions.</p><p><strong>Conclusions: </strong>Referrals from psychiatric institutions, DLB, NMDA receptor antagonist, polypharmacy, and benzodiazepine were associated with antipsychotic prescriptions for patients with dementia. To optimise prescription of antipsychotics, it is necessary to improve cooperation between local and specialised medical institutions for accurate diagnosis, evaluate the effects of concomitant medication administration, and solve the prescribing cascade.</p>","PeriodicalId":11126,"journal":{"name":"Dementia and Geriatric Cognitive Disorders","volume":null,"pages":null},"PeriodicalIF":2.2000,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10614247/pdf/","citationCount":"1","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Dementia and Geriatric Cognitive Disorders","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1159/000531240","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2023/5/26 0:00:00","PubModel":"Epub","JCR":"Q3","JCRName":"CLINICAL NEUROLOGY","Score":null,"Total":0}
引用次数: 1

Abstract

Introduction: Antipsychotics are still commonly prescribed to patients with dementia, despite the many issues that have been identified. This study aimed to quantify antipsychotic prescription in patients with dementia and the types of concomitant medications prescribed with antipsychotics.

Methods: A total of 1,512 outpatients with dementia who visited our department between April 1, 2013 and March 31, 2021, were included in this study. Demographic data, dementia subtypes, and regular medication use at the time of the first outpatient visit were investigated. The association between antipsychotic prescriptions and referral sources, dementia subtypes, antidementia drug use, polypharmacy, and prescription of potentially inappropriate medications (PIMs) was evaluated.

Results: The antipsychotic prescription rate for patients with dementia was 11.5%. In a comparison of dementia subtypes, the antipsychotic prescription rate was significantly higher for patients with dementia with Lewy bodies (DLB) than for those with all other dementia subtypes. In terms of concomitant medications, patients taking antidementia drugs, polypharmacy, and PIMs were more likely to receive antipsychotic prescriptions than those who were not taking these medications. Multivariate logistic regression analysis showed that referrals from psychiatric institutions, DLB, N-methyl-d-aspartate (NMDA) receptor antagonists, polypharmacy, and benzodiazepine were associated with antipsychotic prescriptions.

Conclusions: Referrals from psychiatric institutions, DLB, NMDA receptor antagonist, polypharmacy, and benzodiazepine were associated with antipsychotic prescriptions for patients with dementia. To optimise prescription of antipsychotics, it is necessary to improve cooperation between local and specialised medical institutions for accurate diagnosis, evaluate the effects of concomitant medication administration, and solve the prescribing cascade.

Abstract Image

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
痴呆症患者服用抗精神病药物的疗效分析。
引言:尽管已经发现了许多问题,但抗精神病药物仍然普遍用于痴呆症患者。本研究旨在量化痴呆患者的抗精神病药物处方以及与抗精神病药一起使用的联合药物类型。方法:2013年4月1日至2021年3月31日期间,共有1512名痴呆症门诊患者到我科就诊,纳入本研究。调查了第一次门诊就诊时的人口统计学数据、痴呆症亚型和常规药物使用情况。评估了抗精神病药物处方与转诊来源、痴呆亚型、抗痴呆药物使用、多药治疗和潜在不适当药物处方(PIM)之间的关系。结果:痴呆症患者的抗精神病药物处方率为11.5%。在痴呆亚型的比较中,路易体痴呆症患者(DLB)的抗精神疾病处方率显著高于所有其他痴呆亚型患者。就联合用药而言,服用抗痴呆药物、多药和PIM的患者比不服用这些药物的患者更有可能获得抗精神病药物处方。多因素逻辑回归分析显示,来自精神病院的转诊、DLB、N-甲基-d-天冬氨酸(NMDA)受体拮抗剂、多药治疗和苯二氮卓类药物与抗精神病药物处方有关。结论:精神病院的转诊、DLB、NMDA受体拮抗剂、多药和苯二氮卓类药物与痴呆患者的抗精神病药物处方有关。为了优化抗精神病药物的处方,有必要改善当地和专业医疗机构之间的合作,以进行准确诊断,评估联合用药的效果,并解决处方级联问题。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
CiteScore
4.70
自引率
0.00%
发文量
46
审稿时长
2 months
期刊介绍: As a unique forum devoted exclusively to the study of cognitive dysfunction, ''Dementia and Geriatric Cognitive Disorders'' concentrates on Alzheimer’s and Parkinson’s disease, Huntington’s chorea and other neurodegenerative diseases. The journal draws from diverse related research disciplines such as psychogeriatrics, neuropsychology, clinical neurology, morphology, physiology, genetic molecular biology, pathology, biochemistry, immunology, pharmacology and pharmaceutics. Strong emphasis is placed on the publication of research findings from animal studies which are complemented by clinical and therapeutic experience to give an overall appreciation of the field.
期刊最新文献
Toolkit to Examine Lifelike Language (TELL) v.2.0: Optimizing speech biomarkers of neurodegeneration. Current Advances in Computerised Cognitive Assessment for Mild Cognitive Impairment and Dementia in Older Adults: A systematic Review. Risperidone for the Treatment of Dementia-Related Psychosis: A Systematic Review and Meta-Analysis. Differential Item Functioning and Clinical Utility of the Subjective Memory Complaints Questionnaire in a Multi-Ethnic Cohort. Efficacy of acetylcholinesterase inhibitors in the logopenic variant of primary progressive aphasia.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1